Evidence map›Paper›PMID 38633399›Full record

ArticleInfectious diseases & clinical microbiology2022

Mert Kılıç, Yeşim Beşli, Ersin Köseoğlu, Erhan Kerim Palaoğlu, Tarık Esen

Abstract read
In one paragraph

Article in Infectious diseases & clinical microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mert KılıçDepartment of Urology, VKF American Hospital, İstanbul, Turkey.ORCID https://orcid.org/0000-0003-1707-3890
Yeşim BeşliDepartment of Microbiology, VKF American Hospital, İstanbul, Turkey.ORCID https://orcid.org/0000-0003-4574-6036
Ersin KöseoğluDepartment of Urology, Koç University School of Medicine, İstanbul, Turkey.ORCID https://orcid.org/0000-0002-5189-0600
Erhan Kerim PalaoğluDepartment of Clinical Laboratory, VKF American Hospital, İstanbul, Turkey.ORCID https://orcid.org/0000-0001-9706-9378
Tarık EsenDepartment of Urology, VKF American Hospital, İstanbul, Turkey.ORCID https://orcid.org/0000-0002-0961-9374

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aimed to investigate the detection rate of Materials and Methods: A total of 144 male patients who presented to our department between February 2021 and October 2021, either with urinary symptoms or concerns following unprotected sex, were included in the study.A total of 128 (88.9%) first-void urine samples, 15 (10.4%) urethral swabs, and one (0.7%) semen sample were obtained. NeoPlex STI-14 Detection Multiplex PCR Kit (GeneMatrix Inc. Seongnam, South Korea) was used to investigate any of the following pathogens: Results: The patients' median age was 37 (range: 21 to 71 years old). Conclusion: With the introduction of multiplex PCR tests, including those for

Indexed as

Gardnerella vaginalismalepolymerase chain reactionurethritis

Identifiers

PMID38633399
PMCPMC10986695

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.